Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects.
Michael BoettcherDirk ThomasWolfgang MueckStephanie LoewenErich ArensKenichi YoshikawaCorina BeckerPublished in: European journal of clinical pharmacology (2020)
EudraCT: 2011-001627-21; EudraCT: 2012-000953-30.
Keyphrases